Analysis of Peripheral T-cell Lymphoma Diagnostic Workup in the United States.

Citation data:

Clinical lymphoma, myeloma & leukemia, ISSN: 2152-2669, Vol: 17, Issue: 4, Page: 193-200

Publication Year:
2017
Usage 39
Abstract Views 38
Link-outs 1
Captures 9
Exports-Saves 8
Readers 1
Citations 2
Citation Indexes 2
PMID:
28209473
DOI:
10.1016/j.clml.2016.10.001
Author(s):
Hsi, Eric D; Horwitz, Steven M; Carson, Kenneth R; Pinter-Brown, Lauren C; Rosen, Steven T; Pro, Barbara; Federico, Massimo; Gisselbrecht, Christian; Schwartz, Marc; Bellm, Lisa A; Acosta, Mark; Collie, Angela M; Gruver, Aaron M; Grzywacz, Bartosz J; Turakhia, Samir; Shustov, Andrei R; Advani, Ranjana H; Feldman, Tatyana; Lechowicz, Mary Jo; Smith, Sonali M; Lansigan, Frederick; Tulpule, Anil; Craig, Michael D; Greer, John P; Kahl, Brad S; Leach, Joseph W; Morganstein, Neil; Casulo, Carla; Park, Steven I; Foss, Francine M Show More Hide
Publisher(s):
Elsevier BV
Tags:
Medicine; Biochemistry, Genetics and Molecular Biology
article description
With increased understanding of the unique entities, subtype-specific approaches for peripheral T-cell lymphoma (PTCL) are emerging, and more precise diagnoses are becoming increasingly important. PATIENTSĀ AND METHODS: We analyzed the approach to the histopathologic diagnosis of PTCL using data from the comprehensive oncology measures of peripheral T-cell lymphoma (COMPLETE) study. The COMPLETE trial is a large prospective cohort study of patients with newly diagnosed PTCL in the United States.